Adar Poonawalla, the chief executive officer of Serum Institute of India, predicted that in the upcoming 10 to 15 days, the Covovax vaccine will be approved as a booster dosage against Covid-19. According to Poonawalla, the vaccination effectively protects against the coronavirus type known as Omicron. The CEO of SII spoke with media on Sunday outside of a function at Bharati Vidyapeeth University and said: “Central Government has a lot of stock of Covisheild and also Covovax vaccine will get approval as a booster in the next 10 to 15 days.”
On being asked about the availability of the Covisheild vaccine, and its lack of supply to the state and district, Adar Poonawalla said, “The central government has a lot of stock of Covisheild they can give it to the state, as of now production of Covisheild is at a halt at SII, we can start it if needed but the Covovax vaccine will get approval as a booster in the next 10 to 15 days, it works well against the Omicron variant of coronavirus.”
He added, “During Covid-19, everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge population and also helped 70 to 80 nations, This was all possible because of the leadership of our central government and state governments, healthcare workers, manufacturers, all of whom worked together with one common goal.”
On the occasion of Dr. Patangrao Kadam’s birth anniversary in Maharashtra, NCP leader Sharad Pawar and deputy chief minister Devendra Fadnavis also presented Poonawalla with an award.